Along with the great strides that have been made towards understanding canc
er, has come a realization of the complexity of molecular events that lead
to malignancy. Proteomics-based approaches, which enable the quantitative i
nvestigation of both cellular protein expression levels and protein-protein
interactions involved in signaling networks, promise to define the molecul
es controlling the processes involved in cancer.